Overlooked and ignored, the problem of untouchability continues to be practised and perpetrated in the country. It is a lifetime of misery and humiliation, unimaginable for the relatively privileged but a daily reality for over one-fifth of the country’s 120 crore-plus population, as revealed succinctly in 22 short and easy to view videos under the Article 17 Campaign launched on April 14, 2012 by India Unheard, which claims to be...

-The Telegraph The Centre has clarified that none of the provisions in the Right to Education Act (RTE) will apply to unaided minority institutes, an exemption that can have several implications for some of the most reputable schools in Calcutta. The exemption means unaided minority schools, if they choose to, can reconsider the mandatory auto-promotion policy till Class VIII and explore ways of disciplining students without inflicting physical pain. Although the central clarification...

That this is the first time a compulsory licence has been granted in India is in itself important. INDIA'S long struggle to ensure access to affordable medicines for its people recently took a positive and interesting turn. In early March, just before he demitted office, Controller General of Patents P.H. Kurian passed an order on an application filed by Natco Pharma, headquartered in Hyderabad, requesting a licence to produce an anti-cancer...

-The Times of India Karnataka, reeling under severe drought, has received a body blow: the Centre has withheld its next instalment of grant to a rural job scheme citing five shortcomings in its implementation in the state. "The release of the next instalment of the central share (for the Mahatma Gandhi National Rural Employment Guarantee Scheme) to the state depends very crucially on how it is able to spend the funds...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...